Safety and immunogenicity of the ChAdOx1 nCoV-19 vaccine against SARS-CoV-2: a preliminary report of a phase 1/2, single-blind, randomised controlled trial by Folegatti, PM, Ewer, KJ, Aley, PK, Angus, B, Becker, S, Belij-Rammerstorfer, S, Bellamy, D, Bibi, S, Bittaye, M, Clutterbuck, EA, Dold, C, Faust, SN, Finn, A, Flaxman, AL, Hallis, B, Heath, P, Jenkin, D, Lazarus, R, Makinson, R, Minassian, AM, Pollock, KM, Ramasamy, M, Robinson, H, Snape, M, Tarrant, R, Voysey, M, Green, C, Douglas, AD, Hill, AVS, Lambe, T, Gilbert, SC, Pollard, AJ, Oxford COVID Vaccine Trial Group

Safety and immunogenicity of ChAdOx1 nCoV-19 vaccine administered in a prime-boost regimen in young and old adults (COV002): a single-blind, randomised, controlled, phase 2/3 trial by Ramasamy, MN, Minassian, AM, Ewer, KJ, Flaxman, AL, Folegatti, PM, Owens, DR, Voysey, M, Aley, PK, Angus, B, Babbage, G, Belij-Rammerstorfer, S, Berry, L, Bibi, S, Bittaye, M, Cathie, K, Chappell, H, Charlton, S, Cicconi, P, Clutterbuck, EA, Colin-Jones, R, Dold, C, Emary, KRW, Fedosyuk, S, Fuskova, M, Gbesemete, D, Green, C, Hallis, B, Hou, MM, Jenkin, D, Joe, CCD, Kelly, EJ, Kerridge, S, Lawrie, AM, Lelliott, A, Lwin, MN, Makinson, R, Marchevsky, NG, Mujadidi, Y, Munro, APS, Pacurar, M, Plested, E, Rand, J, Rawlinson, T, Rhead, S, Robinson, H, Ritchie, AJ, Ross-Russell, AL, Saich, S, Singh, N, Pollard, AJ, Oxford COVID Vaccine Trial Group

Single-dose administration and the influence of the timing of the booster dose on immunogenicity and efficacy of ChAdOx1 nCoV-19 (AZD1222) vaccine: a pooled analysis of four random... by Voysey, M, Costa Clemens, SA, Madhi, SA, Folegatti, PM, Aley, PK, Angus, B, Bibi, S, Cicconi, P, Clutterbuck, EA, Dold, C, Emary, KRW, Ewer, KJ, Flaxman, A, Feng, S, Green, CM, Greenland, M, Jenkin, D, Joe, CCD, Kerridge, S, Marchevsky, NG, Minassian, AM, Mujadidi, Y, Phillips, DJ, Plested, E, Ramasamy, M, Ritchie, AJ, Robinson, H, Song, R, Snape, MD, Douglas, AD, Hill, AVS, Lambe, T, Gilbert, SC, Pollard, AJ

Other Authors: “…Oxford COVID Vaccine Trial Group…”

Safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against SARS-CoV-2: An interim analysis of four randomised controlled trials in Brazil, South Africa, and the UK by Voysey, M, Clemens, SAC, Madhi, SA, Weckx, LY, Folegatti, PM, Aley, PK, Angus, B, Baillie, VL, Barnabas, SL, Bhorat, QE, Bibi, S, Briner, C, Cicconi, P, Collins, AM, Colin-Jones, R, Cutland, CL, Darton, TC, Dheda, K, Duncan, CJA, Emary, KRW, Ewer, KJ, Fairlie, L, Faust, SN, Feng, S, Ferreira, DM, Finn, A, Goodman, AL, Green, CM, Green, CA, Heath, PT, Hill, C, Hill, H, Hirsch, I, Hodgson, SHC, Izu, A, Jackson, S, Jenkin, D, Joe, CCD, Kerridge, S, Koen, A, Kwatra, G, Lazarus, R, Lawrie, AM, Lelliott, A, Libri, V, Lillie, PJ, Mallory, R, Mendes, AVA, Milan, EP, Minassian, AM, Lambe, T, Pollard, AJ

Other Authors: “…Oxford COVID Vaccine Trial Group…”

An exploratory analysis of the response to ChAdOx1 nCoV-19 (AZD1222) vaccine in males and females by Marchevsky, NG, Li, G, Aley, P, Costa Clemens, SA, Barrett, JR, Belij-Rammerstorfer, S, Bibi, S, Clutterbuck, E, Dold, C, Felle, S, Flaxman, A, Folegatti, P, Jenkin, D, Gilbert, S, Kelly, S, Lambe, T, Plested, E, Ramasamy, M, Singh, N, Smith, H, Taylor, S, Weckx, L, Pollard, AJ, Voysey, M

Other Authors: “…Oxford COVID Vaccine Trial Group…”

Phase 1/2 trial of SARS-CoV-2 vaccine ChAdOx1 nCoV-19 with a booster dose induces multifunctional antibody responses by Barrett, J, Belij-Rammerstorfer, S, Dold, C, Ewer, KJ, Folegatti, PM, Gilbride, C, Halkerston, R, Hill, J, Jenkin, D, Stockdale, L, Verheul, MK, Aley, PK, Angus, B, Bellamy, D, Berrie, E, Bibi, S, Bittaye, M, Carroll, MW, Cavell, B, Clutterbuck, EA, Edwards, N, Flaxman, A, Fuskova, M, Gorringe, A, Hallis, B, Kerridge, S, Lawrie, AM, Linder, A, Liu, X, Madhavan, M, Makinson, R, Mellors, J, Minassian, A, Moore, M, Mujadidi, Y, Plested, E, Poulton, I, Ramasamy, MN, Robinson, H, Rollier, CS, Song, R, Snape, MD, Tarrant, R, Taylor, S, Thomas, KM, Voysey, M, Watson, MEE, Wright, D, Douglas, AD, Green, CM, Hill, AVS, Lambe, T, Pollard, AJ

Other Authors: “…Oxford COVID Vaccine Trial Group…”

T cell and antibody responses induced by a single dose of ChAdOx1 nCoV-19 (AZD1222) vaccine in a Phase 1/2 clinical trial by Ewer, K, Barrett, J, Belij-Rammerstorfer, S, Lambe, T, Hill, A, Pollard, A, Gilbert, S, Et al.

Other Authors: “…Oxford COVID Vaccine Trial Group…”

Correlates of protection against symptomatic and asymptomatic SARS-CoV-2 infection by Feng, S, Phillips, DJ, White, T, Sayal, H, Aley, PK, Bibi, S, Dold, C, Fuskova, M, Gilbert, SC, Hirsch, I, Humphries, HE, Jepson, B, Kelly, EJ, Plested, E, Shoemaker, K, Thomas, KM, Vekemans, J, Villafana, TL, Lambe, T, Pollard, AJ, Voysey, M

Other Authors: “…Oxford COVID Vaccine Trial Group…”

Reactogenicity and immunogenicity after a late second dose or a third dose of ChAdOx1 nCoV-19 in the UK: a substudy of two randomised controlled trials (COV001 and COV002) by Flaxman, A, Marchevsky, NG, Jenkin, D, Aboagye, J, Aley, PK, Angus, B, Belij-Rammerstorfer, S, Bibi, S, Bittaye, M, Cappuccini, F, Cicconi, P, Clutterbuck, EA, Davies, S, Dejnirattisai, W, Dold, C, Ewer, KJ, Folegatti, PM, Fowler, J, Hill, AVS, Kerridge, S, Minassian, AM, Mongkolsapaya, J, Mujadidi, YF, Plested, E, Ramasamy, MN, Robinson, H, Sanders, H, Sheehan, E, Smith, H, Snape, MD, Song, R, Woods, D, Screaton, G, Gilbert, SC, Voysey, M, Pollard, AJ, Lambe, T

Other Authors: “…Oxford COVID Vaccine Trial group…”

Fertility rates and birth outcomes after ChAdOx1 nCoV-19 (AZD1222) vaccination by Hillson, K, Clemens, SC, Madhi, SA, Voysey, M, Pollard, AJ, Minassian, AM

Other Authors: “…Oxford COVID Vaccine Trial Group…”

Safety and immunogenicity of the ChAdOx1 nCoV-19 (AZD1222) vaccine against SARS-CoV-2 in HIV infection: a single-arm sub-study of a phase 2/3 clinical trial by Frater, J, Ewer, K, Ogbe, A, Pace, M, Adele, S, Adland, E, Aley, P, Ali, M, Ansari, M, Bittaye, M, Brown, A, Brown, H, Cappuccini, F, Dejnirattisai, W, Dold, C, Moreira Folegatti, P, Fowler, J, Jenkin, D, Makinson, R, Marchevsky, N, Mujadidi, Y, Parolini, L, Plested, E, Ramasamy, M, Rhead, S, Robinson, H, Robinson, N, Rongkard, P, Tipoe, T, Zacharopoulou, P, Barnes, E, Goulder, P, Klenerman, P, Screaton, G, Hill, A, Gilbert, S, Pollard, AJ, Lambe, T

Other Authors: “…Oxford COVID Vaccine Trial Group…”